United for Parkinsons

The upcoming EPDA (European Parkinson Disease Association) International congress will bring together  national Parkinson associations from accross Europe. This year EuPaTh (European Parkinson Therapy Centre) will discuss the 4 pillars approach to Parkinson's as well as a proposal for a good…

Read More

Mobile App tracks Parkinson’s

Capturing a patient’s experience outside the doctor’s office has been an ongoing struggle when it comes to treating Parkinson’s disease. But now a new smartphone app can now detect the severity of symptoms in patients with Parkinson’s disease remotely, according…

Read More
Parkinson Food

Food and Parkinson’s

Parkinson’s Disease (PD) is not something you hear a lot of in the news, especially compared to other neurodegenerative diseases like Alzheimer’s, but it affects a significant percentage of the population: one to two percent of Americans over the age…

Read More

New Parkinson Drug Approved

Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) has approved GOCOVRI (amantadine) extended release capsules (previously ADS-5102) for treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic…

Read More

Old drug may have potential disease-modifying effects.

The type 2 diabetes drug exenatide (Bydureon, Byetta, AstraZeneca) has potential disease-modifying effects in Parkinson's disease, results of a randomized, double-blind, placebo-controlled trial suggest. Study results show the glucagon-like peptide-1 (GLP-1) receptor agonist improved off-medication motor scores in patients with…

Read More